Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
24

Summary

Conditions
Neuroblastoma
Type
Interventional
Phase
Phase 2
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Younger than 22 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT02559778
Collaborators
  • Dell, Inc.
  • Beat NB Cancer Foundation
  • K C Pharmaceuticals Inc.
Investigators
Study Chair: Giselle Sholler, MD Beat Childhood Cancer